Lista de obras - Desmond Curran - Dominio Público Uruguay

A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival

artículo científico publicado en 2001

A systematic literature review of herpes zoster incidence worldwide

artículo científico publicado en 2021

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial

artículo científico publicado en 1998

An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses

scientific article published on 15 December 2020

Analysing longitudinal continuous quality of life data with dropout.

artículo científico publicado en 2002

Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States.

artículo científico publicado en 2017

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

artículo científico

Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)

artículo científico publicado en 1997

Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study.

artículo científico publicado en 1998

Budget constraint and vaccine dosing: a mathematical modelling exercise.

artículo científico publicado en 2014

Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study

scientific article published on 01 September 1999

Corrigendum to "German travelers' preferences for travel vaccines assessed by a discrete choice experiment" [Vaccine 36 (2018) 969-978]

scientific article published on 03 May 2018

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States

artículo científico publicado en 2018

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

scientific article published on 20 February 2019

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

scientific article published on 06 September 2018

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

article

Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan

artículo científico publicado en 2017

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group

artículo científico publicado en 1998

Evaluation of two frailty indices, with practical application in a vaccine clinical trial

artículo científico publicado en 2019

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

artículo científico publicado en 2000

German travelers' preferences for travel vaccines assessed by a discrete choice experiment.

artículo científico publicado en 2018

Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis

scientific article published on 27 August 2019

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

artículo científico publicado en 2000

Identifying the types of missingness in quality of life data from clinical trials

artículo científico publicado en 1998

Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study

artículo científico publicado en 2017

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

article

Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.

artículo científico publicado en 2018

Incomplete quality of life data in randomized trials: missing forms

artículo científico publicado en 1998

Incomplete quality of life data in randomized trials: missing items.

artículo científico publicado en 1998

Meta-Regression of Herpes Zoster Incidence Worldwide

artículo científico publicado en 2021

Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

artículo científico publicado en 2002

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

artículo científico publicado en 2000

Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.

artículo científico publicado en 2001

Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gynaecological Cancer Cooperative Group study.

artículo científico publicado en 1997

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

artículo científico publicado en 2002

Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme

artículo científico publicado en 2019

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older

artículo científico publicado en 2019

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

artículo científico publicado en 1998

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

artículo científico publicado en 2012

Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group

artículo científico publicado en 2000

Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

artículo científico publicado en 2003

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

artículo científico publicado en 2007

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G

artículo científico publicado en 1998

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

artículo científico publicado en 2009

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2010

Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.

artículo científico publicado en 2000

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

artículo científico publicado en 1999

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

artículo científico publicado en 1998

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

artículo científico publicado en 2020

Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan

artículo científico publicado en 2017

Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults

artículo científico publicado en 2014

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study

artículo científico publicado en 1996

Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.

artículo científico publicado en 2004

Sensitivity analysis of longitudinal binary quality of life data with drop-out: an example using the EORTC QLQ-C30.

artículo científico publicado en 2001

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial

scientific article published on 01 August 1996

Statistical analysis of quality of life with missing data in cancer clinical trials

artículo científico publicado en 1998

Strategies to fit pattern-mixture models.

artículo científico publicado en 2002

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

artículo científico publicado en 2000

The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy

article

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

scientific article published on 01 July 2019

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.

artículo científico publicado en 2018

The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis

scientific article published on 11 April 2019

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

artículo científico publicado en 2016

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy

artículo científico publicado en 2019

The temporal impact of aging on the burden of herpes zoster

artículo científico publicado en 2017

Vaccine Timeliness: A Cost Analysis of the Potential Implications of Delayed Pertussis Vaccination in the US.

artículo científico publicado en 2016

A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

artículo científico publicado en el año 2000

Lista de obras de Desmond Curran

A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival

A systematic literature review of herpes zoster incidence worldwide

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial

An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses

Analysing longitudinal continuous quality of life data with dropout.

Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States.

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)

Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study.

Budget constraint and vaccine dosing: a mathematical modelling exercise.

Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study

Corrigendum to "German travelers' preferences for travel vaccines assessed by a discrete choice experiment" [Vaccine 36 (2018) 969-978]

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group

Evaluation of two frailty indices, with practical application in a vaccine clinical trial

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

German travelers' preferences for travel vaccines assessed by a discrete choice experiment.

Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

Identifying the types of missingness in quality of life data from clinical trials

Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.

Incomplete quality of life data in randomized trials: missing forms

Incomplete quality of life data in randomized trials: missing items.

Meta-Regression of Herpes Zoster Incidence Worldwide

Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.

Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gynaecological Cancer Cooperative Group study.

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group

Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan

Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study

Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.

Sensitivity analysis of longitudinal binary quality of life data with drop-out: an example using the EORTC QLQ-C30.

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial

Statistical analysis of quality of life with missing data in cancer clinical trials

Strategies to fit pattern-mixture models.

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.

The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy

The temporal impact of aging on the burden of herpes zoster

Vaccine Timeliness: A Cost Analysis of the Potential Implications of Delayed Pertussis Vaccination in the US.

A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients